Chimeric antigen receptor T cells targeting the tumor microenvironment
US12378297B2 · kind B2 · utility
0Cited by
12References
24Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 16, 2018 |
| Grant date | Aug 5, 2025 |
| Priority date | — |
| Expiry date | Jan 17, 2039 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/33
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides methods and compositions for use in treating cancer, which advantageously may be achieved by targeting of the tumor microenvironment.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.